(NY: AORT )Headline News about AORT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Headline News about AORT
Oppenheimer Maintains Outperform Rating for Artivion: Here's What You Need To Know
September 26, 2022
Via Benzinga
Artivion Stock Plunges Apixaban Vs. Warfarin Trial Setback, Reaffirms Annual Guidance
September 23, 2022
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
September 23, 2022
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|